Each proposal in this program project is concerned with cellular
developmental neurobiology. The central hypothesis of these
proposals is that there is a continuous interaction between the
determinants of neuronal form and function, and that these
interactions play an essential role in establishing the
characteristics of the differentiated neuron. Although the basic
analyses by these projects has been at the cellular level, there is
an increased tendency to now carry these through to the
molecular level. This is explicit in the application of hybridoma
techniques by each of the projects. Some will use the monoclonal
antibodies as labels for subsets of neurons to increase the
resolution of the cellular analyses. Others will use the
monoclonal antibodies to directly assist in the identification of
molecules that are directly playing an important role in
developmental processes. This shared interest in the cellular
events occurring during the development of the nervous system
and in the application of hybridoma techniques has resulted in
many productive interactions and direct collaborations among all
participants.
Both invertebrate and vertebrate nervous systems are used in
order to take advantage of specific properties of each. Those
projects examining the factors controlling cell number by
influencing rates of cell production or cell death will contribute
to our understanding of degenerative disorders like Huntington's,
Parkinson's and Alzheimer's diseases. The development of
neuronal control of the endocrine system in cockroaches and
identification of the neuropeptides involved will produce
information useful in regulating excessive populations of insects.
Some projects are studying axon growth - the effect of neuronal
activity on it and the function and regulation of synthesis of
molecules present in cells only during this process. Other projects
study the specificity of synapse formation. Knowledge of the
factors mediating axon growth and synapse formation obtained
from these projects will be useful for developing more rational
therapeutic treatments of neuronal damage from strokes, multiple
sclerosis and direct injury.
National Institute of Neurological Disorders and Stroke
CFDA Code
DUNS Number
062761671
UEI
Z1H9VJS8NG16
Project Start Date
01-July-1979
Project End Date
30-June-1994
Budget Start Date
01-July-1992
Budget End Date
30-June-1994
Project Funding Information for 1992
Total Funding
$543,371
Direct Costs
$379,980
Indirect Costs
$163,391
Year
Funding IC
FY Total Cost by IC
1992
National Institute of Neurological Disorders and Stroke
$543,371
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P01NS015350-14
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P01NS015350-14
Patents
No Patents information available for 5P01NS015350-14
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P01NS015350-14
Clinical Studies
No Clinical Studies information available for 5P01NS015350-14
News and More
Related News Releases
No news release information available for 5P01NS015350-14
History
No Historical information available for 5P01NS015350-14
Similar Projects
No Similar Projects information available for 5P01NS015350-14